GlassScriptPhysician profile
Dara Huang
NPI 1245481555
$10,702.59
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,608 · 2020: $142 · 2022: $124 · 2023: $6,498 · 2024: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,642 · Travel and Lodging: $1,205 · Food and Beverage: $982.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,642.00 |
| Travel and Lodging | $1,205.44 |
| Food and Beverage | $981.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $6,354.36 | 2022-2024 | |
| Gilead Sciences, INC. | $3,150.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $241.68 | 2019-2020 | |
| Amgen INC. | $232.91 | 2019-2023 | Tavneos |
| Mallinckrodt Enterprises LLC | $155.76 | 2019 | |
| Glaxosmithkline, LLC. | $133.51 | 2019-2024 | |
| Otsuka America Pharmaceutical, INC. | $125.00 | 2023 | Jynarque |
| Travere Therapeutics, INC. | $122.43 | 2024 | |
| Horizon Therapeutics Plc | $118.06 | 2023 | Krystexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.40 | 2019 | |
| Vifor Pharma, INC. | $20.25 | 2019 | |
| Opko Pharmaceuticals, LLC | $17.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dara Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.